UK markets closed

INSPIREMD 1/18 DL-,0001 (II2.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.1200+0.0200 (+0.95%)
As of 08:21PM CEST. Market open.
Full screen
Previous close2.1000
Open2.2000
Bid2.0800 x N/A
Ask2.3400 x N/A
Day's range2.0000 - 2.2000
52-week range2.0000 - 2.2000
Volume70
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update

    - Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of 2023 - - Announced that an abstract detailing one-year outcomes from the C-GUARDIANS IDE clinical trial of CGuard™ Prime has been accepted for presentation at LINC 2024, to be held May 28-31 - - Named Patrick Geraghty, M.D. and Patrick Muck, M.D. as lead principal investigators for the Company’s CGUARDIANS II clinical trial for Transcarotid Artery Revascularization (TCAR), as well a

  • GlobeNewswire

    InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th

    -Conference call and webcast to be held at 8:30 a.m. EDT-TEL AVIV, Israel and MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report first quarter 2024 financial results on Tuesday, May 14th, before the financial markets open. Management will host a conference call and webcast with the investment community at 8:30

  • GlobeNewswire

    InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

    TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024. Presentation details: Date:Wednesday, April 10th Time:8:00-8:40 AM ET Webcast:https://wsw.com/webcast/needham13